Latest Asx Listings News

Horizon Minerals has successfully raised $4.65 million through a Share Purchase Plan, supplementing a recent $175 million placement as it advances its Black Swan processing hub development.

IperionX Limited has denied any undisclosed information following a sharp share price drop from $6.93 to $4.58, clarifying its accounting for U.S. government grants amid market volatility.

Saferoads Holdings Limited is initiating a buy-back of unmarketable share parcels under $500, offering shareholders a simple, cost-free exit at $0.10 per share. Shareholders must opt out by 30 April to retain their holdings.

Classic Minerals has engaged AFDC to conduct a strategic review and is raising A$3 million to advance exploration at its Forrestania gold project and support its ASX relisting efforts.

H&G High Conviction Limited has been suspended from ASX trading due to failing to meet operational requirements, raising questions about its future as a listed entity.

Lithium Energy Limited has revealed a detailed two-year, $36 million plan to advance its battery minerals projects, supported by a robust $68 million cash position as it prepares for ASX relisting.

Westgold Resources has completed the demerger of its non-core Reedy and Comet Projects to newly formed Valiant Gold, which has attracted $75 million in oversubscribed IPO applications ahead of its ASX debut.

Manhattan Gold Limited has clarified recent share price and volume spikes, attributing them to strategic corporate communications and a fresh investor research report.

WA Kaolin Limited has responded to ASX queries clarifying that its Q2 FY2026 order book was a demand snapshot, not a sales forecast, and confirmed timely disclosure of a production shortfall linked to plant issues. The company also addressed regulatory notices, affirming no material impact on operations or securities value.

ActivEX Limited has secured $421,753 through a placement of over 21 million shares at a slight discount, locking in investors for 12 months. The funds aim to boost exploration projects and shore up working capital.

Oncosil Medical Ltd’s OSLOE securities have been suspended from trading by the ASX due to non-compliance with listing rules, raising questions about the company’s next steps.

Atlas Pearls Ltd has disclosed a significant 27% revenue decline and a net loss for the half year ended December 2025, attributing the results to weaker auction outcomes and one-off accounting impacts. The company affirms timely disclosure and compliance with ASX rules amid market sensitivity.